We have very few HBeAg positive patients here in Europe.
在欧洲,我们e抗原阳性的患者很少。
2
Early research has shown that a 48-week course of adefovir provides clinical improvements in patients with HBeAg-negative chronic hepatitis B.
早期的研究已经显示,对慢性乙型肝炎e抗原阴性的患者进行48周阿德福韦治疗后,获得了临床上的改善。
3
Current antiviral treatment can successfully control the HBV replication, and can induce HBeAg seroconversion in some patients with chronic HBV infection.